Document and Entity Information |
Jul. 22, 2026 |
|---|---|
| Document Information [Line Items] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Document Period End Date | Jul. 22, 2026 |
| Entity Registrant Name | NOVANTA INC. |
| Entity Central Index Key | 0001076930 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-35083 |
| Entity Incorporation, State or Country Code | A3 |
| Entity Tax Identification Number | 98-0110412 |
| Entity Address, Address Line One | 125 Middlesex Turnpike |
| Entity Address, City or Town | Bedford |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 01730 |
| City Area Code | 781 |
| Local Phone Number | 266-5700 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Amendment Description | As previously disclosed by Novanta Inc., a New Brunswick corporation (the “Company”) in the Current Report on Form 8-K filed on June 9, 2026 (the “Previous Form 8-K”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“Buyer”), Novanta Corporation, a Michigan corporation (“Intermediate Parent”, and together with the Company and the Buyer, the “Buyer Parties”), Runway Midco, LLC, a Delaware limited liability company (“Seller”), and Runway Buyer, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Seller (“Runway Buyer”), entered into an Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which Buyer agreed to acquire from Seller all of the issued and outstanding limited liability company interests (the “Purchased Interests”) of Runway Buyer (the “Transaction”). On July 23, 2026, the closing of the Transaction (the “Closing”) occurred. This Current Report on Form 8-K/A is filed as an amendment to the Current Report on Form 8-K filed by the Company on July 27, 2026, pursuant to Item 9.01(a)(3) and (b)(2) of Form 8-K, to include the financial information required pursuant to Item 9.01(a) and (b) of Form 8-K. |
| Common Shares | |
| Document Information [Line Items] | |
| Title of 12(b) Security | Common shares, no par value |
| Trading Symbol | NOVT |
| Security Exchange Name | NASDAQ |
| 6.50% Tangible Equity Units | |
| Document Information [Line Items] | |
| Title of 12(b) Security | 6.50% Tangible Equity Units |
| Trading Symbol | NOVTU |
| Security Exchange Name | NASDAQ |